BREAST LOBULAR CARCINOMA IN SITU
Clinical trials for BREAST LOBULAR CARCINOMA IN SITU explained in plain language.
Never miss a new study
Get alerted when new BREAST LOBULAR CARCINOMA IN SITU trials appear
Sign up with your email to follow new studies for BREAST LOBULAR CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug acolbifene takes on tamoxifen in breast cancer prevention showdown
Prevention Recruiting nowThis study tests whether a new drug, acolbifene, works better than a low dose of tamoxifen to prevent breast cancer in premenopausal women at high risk. Both drugs block estrogen, which can fuel breast cancer growth. About 80 women will take one of the two pills for six months, a…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 16, 2026 12:52 UTC
-
Could your diet lower breast cancer risk? new study investigates
Prevention Recruiting nowThis study follows 960 women at high risk for breast cancer to see if their diet's ability to cause inflammation is linked to developing the disease. Participants are already being monitored in a prevention clinic. The goal is to find modifiable risk factors to improve prevention…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Prevention
Last updated Jun 16, 2026 12:50 UTC
-
Can fish oil boost Tamoxifen's power to prevent breast cancer?
Prevention Recruiting nowThis study tests whether adding high-dose omega-3 fatty acids to low-dose tamoxifen can better reduce breast cancer risk in overweight postmenopausal women who are already at higher risk. Tamoxifen blocks estrogen in breast tissue, while omega-3s may help with metabolism-related …
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 15, 2026 18:55 UTC
-
Could a lower tamoxifen dose prevent breast cancer in high-risk women?
Prevention Recruiting nowThis study is for premenopausal women at higher-than-average risk for breast cancer. It tests whether a low dose of tamoxifen can safely reduce breast density, which is linked to cancer risk. About 200 women will take tamoxifen, and doctors will adjust the dose if needed to get t…
Matched conditions: BREAST LOBULAR CARCINOMA IN SITU
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 12, 2026 12:05 UTC